eMedicine Specialties > Pediatrics: General Medicine > Pulmonology
Loffler Syndrome: Treatment & Medication
Updated: Jul 2, 2009
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
- Multimedia
Treatment
Medical Care
Evaluation of Löffler syndrome can be conducted on an outpatient basis; inpatient care is not required.
Surgical Care
Surgical care is not indicated.
Consultations
Pediatric pulmonologist
Diet
No special diet is required.
Activity
No activity limitation is indicated.
Medication
The minimal nature of symptoms in most patients with Löffler syndrome usually denotes that no pharmacologic therapy is required for this self-limiting condition. For drug-induced pulmonary eosinophilia, discontinue administration of the offending drug. When a parasitic infection is documented, appropriate use of anthelmintic drugs is indicated. In severe cases of simple pulmonary or drug-induced eosinophilia, systemic corticosteroids are highly effective.
Corticosteroids
Markedly reduce the survival of certain inflammatory cells, including eosinophils. Eosinophil survival is dependent on the presence of certain cytokines (eg, interleukin-5 [IL-5], granulocyte macrophage colony stimulating factor and [GM-CSF]), whose effects are blocked by administration of corticosteroids.
Prednisone (Deltasone, Meticorten, Orasone, Sterapred)
May decrease inflammation by reversing increased capillary permeability and suppressing PMN activity.
Adult
5-60 mg/d PO divided qd/bid
Pediatric
0.5-2 mg/kg/d PO divided qd/bid; not to exceed 80 mg/d
Concurrent use with digoxin may cause digitalis toxicity secondary to hypokalemia; phenobarbital, phenytoin, and rifampin may increase metabolism of glucocorticoids (consider increasing maintenance dose); monitor for hypokalemia with coadministration of diuretics
Documented hypersensitivity; administration of corticosteroids to patients with S stercoralis infection (may lead to hyperinfection syndrome)
Pregnancy
B - Usually safe but benefits must outweigh the risks.
Precautions
Use with much caution in patients with peptic ulcer disease, hypertension, psychoses, diabetes, osteoporosis, varicella, and herpes infection; do not discontinue abruptly following use > 2 wk; observe carefully for the development of hyperglycemia, glycosuria, sodium retention with edema or hypertension, hypokalemia, peptic ulcer, osteoporosis, or hidden infections
More on Loffler Syndrome |
| Overview: Loffler Syndrome |
| Differential Diagnoses & Workup: Loffler Syndrome |
Treatment & Medication: Loffler Syndrome |
| Follow-up: Loffler Syndrome |
| Multimedia: Loffler Syndrome |
| References |
| Further Reading |
| « Previous Page | Next Page » |
References
Crofton JW, Livingstone JL, Oswald NC, Roberts AT. Pulmonary eosinophilia. Thorax. Mar 1952;7(1):1-35. [Medline].
Hara A, Nagase H, Hayashi H, Kuramochi M, Ishida H, Adachi T, et al. [A case of allergic bronchopulmonary aspergillosis complicated with lung abscess which developed into a bronchopleural fistula]. Nihon Kokyuki Gakkai Zasshi. May 2009;47(5):432-7. [Medline].
Janz DR, O'Neal HR Jr, Ely EW. Acute eosinophilic pneumonia: A case report and review of the literature. Crit Care Med. Apr 2009;37(4):1470-4. [Medline].
Pisarczyk-Wiza D, Wierusz-Wysocka B. [Churg-Strauss syndrome: diagnostic and therapeutic challenge - a case report]. Kardiol Pol. Apr 2009;67(4):410-4. [Medline].
[Guideline] Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of respiratory illness in children and adults. Jan 2008;[Full Text].
Alberts WM. Eosinophilic interstitial lung disease. Curr Opin Pulm Med. Sep 2004;10(5):419-24. [Medline].
Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med. Nov 1994;150(5 Pt 1):1423-38. [Medline].
Carroll JL, Sterni LM. Eosinophilic lung disorders and hypersensitivity pneumonitis. In: Taussig LM, Landau LI, eds. Pediatric Respiratory Medicine. St Louis, Mo: Mosby; 1999:804-10.
Corrin B. The lungs. In: Systemic Pathology. 3rd ed. London, England: Churchill Livinstone; 1990:191.
Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy. Jul 2005;60(7):841-57. [Medline].
Das AM, Williams TJ, Lobb R, Nourshargh S. Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model. Immunology. Jan 1995;84(1):41-6. [Medline].
Fujimura M, Yasui M, Shinagawa S, et al. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and drug-induced eosinophilic pneumonia. Respir Med. May 1998;92(5):743-9. [Medline].
Kaufman J, O'Shaughnessy IM. Eosinophilic pleural effusion associated with valproic acid administration. South Med J. Aug 1995;88(8):881-2. [Medline].
Kim Y, Lee KS, Choi DC, et al. The spectrum of eosinophilic lung disease: radiologic findings. J Comput Assist Tomogr. Nov-Dec 1997;21(6):920-30. [Medline].
Lee HK, Jin SL, Lee HP, et al. Loffler's syndrome associated with Clonorchis sinensis infestation. Korean J Intern Med. Dec 2003;18(4):255-9. [Medline].
Ler WZ. Differential-diagnose der lungen infiltrierungen: er fle succedan-infiltrate (mit eosinophilia). Beitr Klin Tuberk. 1932;79:368-92.
Nadeem S, Nasir N, Israel RH. Loffler's syndrome secondary to crack cocaine. Chest. May 1994;105(5):1599-600. [Medline].
Neva FA, Brown HW. Intestinal nematodes. In: Basic Clinical Parasitology. 6th ed. Norwalk, Conn: Appleton & Lange; 1994:113-51.
Nogami M, Suko M, Okudaira H, et al. Experimental pulmonary eosinophilia in mice by Ascaris suum extract. Am Rev Respir Dis. May 1990;141(5 Pt 1):1289-95. [Medline].
O'Sullivan BP, Nimkin K, Gang DL. A fifteen-year-old boy with eosinophilia and pulmonary infiltrates. J Pediatr. Oct 1993;123(4):660-6. [Medline].
Ohnishi H, Abe M, Yokoyama A, et al. Clarithromycin-induced eosinophilic pneumonia. Intern Med. Mar 2004;43(3):231-5. [Medline].
Pawlowski ZS. Ascariasis. In: Warren KS, Mahmoud AAF, eds. Tropical and Geographical Medicine. 2nd ed. New York, NY: McGraw-Hill; 1990:369.
Sharma OP, Bethlem EP. The pulmonary infiltration with eosinophilia syndrome. Curr Opin Pulm Med. Sep 1996;2(5):380-9. [Medline].
Takafuji S, Nakagawa T. Drug-induced pulmonary disorders. Intern Med. Mar 2004;43(3):169-70. [Medline].
Wang J, Palmer K, Lotvall J, et al. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J Clin Invest. Sep 15 1998;102(6):1132-41. [Medline]. [Full Text].
Wong-Waldamez A, Silva-Lizama E. Bullous larva migrans accompanied by Loeffler's syndrome. Int J Dermatol. Aug 1995;34(8):570-1. [Medline].
Further Reading
- Relevant clinical guidelines and clinical trials include the following:
- Related eMedicine topics include the following:
Keywords
Loffler syndrome, Löffler's syndrome, allergic bronchopulmonary helminthiasis, drug-induced pulmonary eosinophilia, simple pulmonary eosinophilia, parasitic infections, hypersensitivity reactions, eosinophilic pulmonary infiltrates, ascariasis, treatment, diagnosis
Treatment & Medication: Loffler Syndrome